The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Janice C. Parker

Department of Cardiovascular and Metabolic Diseases

Pfizer Inc.

Groton

Connecticut 06340

USA

[email]@*.pfizer.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Cardiovascular and Metabolic Diseases, Pfizer Inc., Groton, Connecticut 06340, USA. 1998 - 2004
  • Pfizer Global Research & Development, Groton Laboratories, 8220-0375, Eastern Point Road, USA. 2002 - 2004
  • Pfizer Inc., Central Research Division, Groton, Connecticut 06340, USA. 1997 - 2002

References

  1. Preclinical studies and clinical trials for diabetes-second annual forum: identifying emerging therapies and improve trial efficiency. Parker, J. IDrugs (2004) [Pubmed]
  2. Synergistic effect on insulin secretion from INS-1 cells of a sulfonylurea and a phosphodiesterase 3 inhibitor. Parker, J.C., VanVolkenburg, M.A., Gao, F. Life Sci. (2004) [Pubmed]
  3. Glycemic control in mice with targeted disruption of the glucagon receptor gene. Parker, J.C., Andrews, K.M., Allen, M.R., Stock, J.L., McNeish, J.D. Biochem. Biophys. Res. Commun. (2002) [Pubmed]
  4. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus. Parker, J.C. Adv. Drug Deliv. Rev. (2002) [Pubmed]
  5. Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes. Parker, J.C., McPherson, R.K., Andrews, K.M., Levy, C.B., Dubins, J.S., Chin, J.E., Perry, P.V., Hulin, B., Perry, D.A., Inagaki, T., Dekker, K.A., Tachikawa, K., Sugie, Y., Treadway, J.L. Diabetes (2000) [Pubmed]
  6. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. Parker, J.C., VanVolkenburg, M.A., Levy, C.B., Martin, W.H., Burk, S.H., Kwon, Y., Giragossian, C., Gant, T.G., Carpino, P.A., McPherson, R.K., Vestergaard, P., Treadway, J.L. Diabetes (1998) [Pubmed]
  7. Structure-function analysis of a series of glucagon-like peptide-1 analogs. Parker, J.C., Andrews, K.M., Rescek, D.M., Massefski, W., Andrews, G.C., Contillo, L.G., Stevenson, R.W., Singleton, D.H., Suleske, R.T. J. Pept. Res. (1998) [Pubmed]
  8. Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III. Parker, J.C., VanVolkenburg, M.A., Nardone, N.A., Hargrove, D.M., Andrews, K.M. Biochem. Biophys. Res. Commun. (1997) [Pubmed]
 
WikiGenes - Universities